PELOTON THERAPEUTICS
A peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and ... management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton's vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.
PELOTON THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.pelotontherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
972-629-4100
Email Addresses:
[email protected]
Total Funding:
242.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Microsoft Exchange Online Office 365 Mail
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spencer Health Solutions
Spencer Health Solutions is a developer of an in-home medication dispenser.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eventide
Eventide investment in Series E - Peloton Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series E - Peloton Therapeutics
OrbiMed
OrbiMed investment in Series E - Peloton Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series E - Peloton Therapeutics
Tichenor Ventures
Tichenor Ventures investment in Series E - Peloton Therapeutics
Topspin Partners
Topspin Partners investment in Series E - Peloton Therapeutics
Jim Tananbaum
Jim Tananbaum investment in Series E - Peloton Therapeutics
The Column Group
The Column Group investment in Series E - Peloton Therapeutics
Nextech Invest
Nextech Invest investment in Series E - Peloton Therapeutics
Vida Ventures
Vida Ventures investment in Series E - Peloton Therapeutics
Newest Events participated
Official Site Inspections
http://www.pelotontherapeutics.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Peloton Therapeutics"
Peloton Therapeutics - 2025 Company Profile & Team
Peloton Therapeutics is an acquired company based in Dallas (United States), founded in 2010 by Michael S Brown and Steven McKnight. It operates as a …See details»
Peloton Therapeutics - Crunchbase Company Profile
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.See details»
Peloton Therapeutics Company Profile - Office Locations ... - Craft
See insights on Peloton Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Merck & Co to buy cancer biotech Peloton for $2.2bn
3 days ago Merck & Co is to buy the privately-held biotech Peloton for up to $2.2 billion, adding further oncology drugs to its pipeline.See details»
Peloton Therapeutics Inc - Company Profile and News
Company profile page for Peloton Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Peloton Therapeutics Inc. - UT Southwestern Medical Center
Founded in 2011, Peloton Therapeutics Inc. is an oncology drug discovery and development company advancing first-in-class small molecule therapies that provide patients suffering from …See details»
Peloton Therapeutics 2025 Company Profile: Valuation, Funding ...
Peloton Therapeutics Inc is a clinical stage biopharmaceutical company focused on translating novel scientific insights into medicines for patients with cancer and other debilitating or life …See details»
Peloton Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Peloton Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 91 news, and 14 literature, Disease Domain ...See details»
Peloton Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Peloton Therapeutics, Inc. of Dallas, TX. Get the latest business insights from Dun & Bradstreet.See details»
Merck buys Peloton Therapeutics to expand its kidney cancer
May 21, 2019 U.S. drugmaker Merck on Tuesday agreed to buy Peloton Therapeutics for $1.05 billion in cash, gaining access to the privately held company’s lead kidney cancer drug …See details»
Peloton Therapeutics - Ownership and Business Overview - Mergr
Peloton Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other …See details»
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
May 21, 2019 Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. today announced that the companies have entered into a definitive …See details»
Merck buys cancer firm Peloton | C&EN Global Enterprise
May 27, 2019 Aiming to bolster its late-stage oncology pipeline, Merck & Co. will pay up to $2.2 billion to acquire privately held Peloton Therapeutics. The Dallas-based biotech firm gives …See details»
Peloton Therapeutics - VentureRadar
Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton …See details»
Merck signs $1bn deal to acquire Peloton Therapeutics
Merck has signed a definitive agreement to acquire biopharmaceutical company Peloton Therapeutics for an upfront payment of $1.05bn. The deal includes an additional $1.15bn in …See details»
Peloton Therapeutics - Funding, Financials, Valuation & Investors
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.See details»
Peloton Therapeutics Revenue, Growth & Competitor Profile
May 19, 2025 Note: Revenues for privately held companies are statistical evaluations. Peloton Therapeutics's Annual Report & Profile shows critical firmographic facts: What is the …See details»
Dallas’ Peloton Therapeutics Exits to Merck in $2.2B Deal
May 22, 2019 Just weeks after Dallas-based Peloton Therapeutics filed for an initial public offering, pharmaceutical giant Merck & Co. announced it is buying the biotech company in a …See details»
Merck Buys Peloton Therapeutics in $2.2 Billion Deal
May 21, 2019 Merck is buying all outstanding shares of Peloton, a clinical-stage oncology company, for an upfront payment of $1.05 billion in cash. Peloton will also be eligible for …See details»
Cancer Treatments Spur Merck Acquisition Of Peloton …
May 21, 2019 Dow Jones component Merck will spend up to $2.2 billion to buy privately held biotech Peloton Therapeutics for its cancer treatments.See details»